ES2047149T3 - Procedimiento para la obtencion de compuestos complejos. - Google Patents

Procedimiento para la obtencion de compuestos complejos.

Info

Publication number
ES2047149T3
ES2047149T3 ES89810018T ES89810018T ES2047149T3 ES 2047149 T3 ES2047149 T3 ES 2047149T3 ES 89810018 T ES89810018 T ES 89810018T ES 89810018 T ES89810018 T ES 89810018T ES 2047149 T3 ES2047149 T3 ES 2047149T3
Authority
ES
Spain
Prior art keywords
procedure
beta
complex compounds
metal ion
dicarbonyl compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810018T
Other languages
English (en)
Inventor
Heinrich H Dr Peter
Theophile Moerker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2047149T3 publication Critical patent/ES2047149T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C07F19/005—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00 without metal-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA OBTENCION DE COMPLEJOS DE CHELATO QUE PUEDEN UTILIZARSE EN LA MEDICINA DIAGNOSTICA, POR EJEMPLO COMO MEDIO DE CONTRASTE O RADIOTERAPEUTICO. EN ESTE PROCESO SE RECOMPLEJIZA UN COMPLEJO DE UN COMPUESTO DE (BETA) - DICARBONILO Y UN ION METALICO, POR EJEMPLO UN METAL - ACETIL - ACETONATO, EL CUAL SE PUEDE DILUIR BNIEN EN UNA SOLUCION ORGANICA MEZCLABLE CON AGUA, CON UNA CANTIDAD ESTEQUIOMETRICA O UN DEFICIT DE UN CHELATIFICADOR, CUYA AFINIDAD DE ENLACE AL ION METALICO SEA MAS ALTA DE LA DEL COMPUESTO DE (BETA) DICARBONILO.
ES89810018T 1988-01-20 1989-01-11 Procedimiento para la obtencion de compuestos complejos. Expired - Lifetime ES2047149T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH18488 1988-01-20

Publications (1)

Publication Number Publication Date
ES2047149T3 true ES2047149T3 (es) 1994-02-16

Family

ID=4181183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810018T Expired - Lifetime ES2047149T3 (es) 1988-01-20 1989-01-11 Procedimiento para la obtencion de compuestos complejos.

Country Status (10)

Country Link
US (1) US5051523A (es)
EP (1) EP0325559B1 (es)
JP (1) JP2633944B2 (es)
AT (1) ATE98631T1 (es)
CA (1) CA1329208C (es)
DE (1) DE58906384D1 (es)
DK (1) DK170048B1 (es)
ES (1) ES2047149T3 (es)
IE (1) IE62816B1 (es)
PT (1) PT89476B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
IL91047A (en) * 1989-07-19 1993-06-10 Yissum Res Dev Co Zinc complexes for the treatment of free radical- induced diseases
AU7346091A (en) * 1990-03-02 1991-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparations for mr diagnosis
US5196412A (en) * 1991-03-06 1993-03-23 Johnson Matthey, Inc. Gallium compounds
WO1993003045A1 (en) * 1991-08-09 1993-02-18 The Regents Of The University Of California Process for purer organic metal ion chelate complexes
IL106064A (en) * 1993-06-18 1997-11-20 Yissum Res Dev Co Gallium complexes for the treatment of free radical-induced diseases
ES2244967T3 (es) * 1995-09-29 2005-12-16 Novartis Ag Nuevas hidroxipiridinonas.
US5886173A (en) * 1997-07-30 1999-03-23 Pharmacyclics, Inc. Metallation of macrocycles with 2,4-dicarbonyl-metal complexes
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US7112671B2 (en) * 2000-08-30 2006-09-26 Pharmacyclics, Inc. Non-symmetric tripyrranes in the synthesis of novel macrocycles
AU2003270473A1 (en) 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
ES2732625T3 (es) 2005-04-04 2019-11-25 Univ Florida Análogos de poliéter de desferritiocina
WO2007002109A2 (en) * 2005-06-20 2007-01-04 The Regents Of The University Of California Multidentate pyrone-derived chelators for medicinal imaging and chelation
US20100137346A1 (en) * 2006-12-12 2010-06-03 University Of Florida Research Foundation, Inc. Desferrithiocin analogue actinide decorporation agents
DE102007008655A1 (de) 2007-02-20 2008-08-21 Henkel Ag & Co. Kgaa Siderophor-Metall-Komplexe als Bleichkatalysatoren
CN104003955A (zh) 2007-03-15 2014-08-27 佛罗里达大学研究基金公司 去铁硫辛聚醚类似物
EP2697352A1 (en) * 2011-04-12 2014-02-19 The Procter and Gamble Company Metal bleach catalysts
BR112014014544A2 (pt) 2011-12-16 2017-06-13 Univ Florida usos de análogos de 4'-desferritiocina
US10010535B2 (en) 2013-11-22 2018-07-03 University Of Florida Research Foundation, Incorporated Desferrithiocin analogs and uses thereof
EP3236970B1 (en) * 2014-12-22 2020-12-16 Mordechai Chevion New metal complexes of nocardamine and their use in pharmaceutical compositions
WO2016176343A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
AU2017242901B2 (en) * 2016-03-31 2020-11-19 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634407A (en) * 1969-06-19 1972-01-11 Ciba Geigy Corp Heavy metal complexes of trihydroxamic acids
EP0045281B1 (de) * 1980-07-28 1985-05-08 Ciba-Geigy Ag Thiazolinderivate und Verfahren zu ihrer Herstellung
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4758422A (en) * 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
EP0232751B1 (en) * 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs

Also Published As

Publication number Publication date
EP0325559A2 (de) 1989-07-26
EP0325559B1 (de) 1993-12-15
DE58906384D1 (de) 1994-01-27
DK22589A (da) 1989-07-21
DK170048B1 (da) 1995-05-08
ATE98631T1 (de) 1994-01-15
EP0325559A3 (en) 1990-11-22
IE890160L (en) 1989-07-20
CA1329208C (en) 1994-05-03
DK22589D0 (da) 1989-01-19
PT89476B (pt) 1993-12-31
JPH0276827A (ja) 1990-03-16
JP2633944B2 (ja) 1997-07-23
IE62816B1 (en) 1995-03-08
US5051523A (en) 1991-09-24
PT89476A (pt) 1990-02-08

Similar Documents

Publication Publication Date Title
DK22589A (da) Fremgangsmaade til fremstilling af kompleksforbindelser
NZ222677A (en) Pharmaceutical compositions and diagnostic agents comprising metal chelate complexes and additional metal complexing agent and/or weak metal chelate to enhance tolerance
NO822199L (no) Vaskemiddelforbindelser og -blandinger.
SE8000074L (sv) Kontrastmedel
NO894326D0 (no) Fremgangsmaate for fremstilling av et bufunksjonelt chelateringsmiddel.
ATE38992T1 (de) Herstellung von uebergangsmetallkomplexen.
RU93004696A (ru) Способ адсорбции с применением таннина
ES2058922T3 (es) Agentes 99m tc(iii) de contraste para el miocardio, eficaces en el hombre.
BR9106242A (pt) Processo para producao de um agente aglutinante hidraulico (i)
EP0194901A3 (en) Isoprenoidamine derivatives, compositions containing them, their preparation, and their use
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE
ATE103967T1 (de) Verfahren zur herstellung von addukten von 1,2butylenoxid an alkohole.
MX9203600A (es) Aductos de tris(isonitrilo)cobre(i) para preparar complejos de radionuclidos.
DE3671452D1 (de) Technetium-aren-komplexe und verfahren.
EP0063328A3 (en) Compositions containing secretin and method for preventing the adsorption of secretin
JPS53122673A (en) Method of treating chromium-containing powdery substance
JPS53142525A (en) Industrial anti-bacterial anti-fungal agent
SU533598A1 (ru) Фосфорорганические тиоамиды в качестве комплексообразующих реагентов в аналитической химии
DE69131401D1 (de) Tc(III)-99m MITTEL ZUR MYOKARDIALEN DARSTELLUNG UND VERFAHREN ZUR VERWENDUNG
ES366190A1 (es) Procedimiento para la preparacion de fenilureas.
ZA761621B (en) Chromated copper arsenate wood preservative compositions
SE7900341L (sv) Inhibitorkomposition av ditiokarbamat/sulfoniumsalt

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 325559

Country of ref document: ES